9 results
Prostanoid prescribing and management in Pulmonary Arterial Hypertension (PAH)
Oral Prostanoids:
 - Selexipag
 - Treprostinil
Inhaled Prostanoids
 -
prescribing and management ... in Pulmonary Arterial ... Hypertension (PAH ... #Hypertension #PAH ... #treatment #pharmacology
Amiodarone Toxicity and Monitoring

Tremor Ataxia 
Ocular neuritis 
Corneal Microdeposits 
Bradycardia 
Pulmonary fibrosis 
Hepatotoxicity 
Blue-gray skin
Amiodarone Toxicity ... Bradycardia Pulmonary ... Considerations - Large ... Adverse #Diagnosis #Management ... #Pharmacology
Low / Intermediate Risk Pulmonary Arterial Hypertension (PAH) Management Algorithm

Dr. John Ryan @JJRyanMD

#Pulmonary #Arterial #Hypertension #PAH
Intermediate Risk Pulmonary ... Hypertension (PAH ... ) Management Algorithm ... #Hypertension #PAH ... #treatment #pharmacology
Heart Failure with Preserved Ejection Fraction: Management Principles

General Therapeutic Principles:
Reduce the congestive state 
 - Caution
Ejection Fraction: Management ... hypertension, pulmonary ... #Cardiology #HFpEF ... dCHF #Diastolic #Treatment ... #HeartFailure #
Amiodarone Induced Lung Toxicity Summary

Who?
• 5% of patients
• Dose ≥ 400 mg per day

How?  Possible
treatment) • Can ... pneumonia, ARDS, DAH ... pulmonary toxicity ... macrophages Treatment ... #diagnosis #management
Severe Heart Failure & Cardiogenic Shock - Management Checklist 
Evaluation 
 - EKG & echocardiography
Cardiogenic Shock - Management ... edema - Large ... Revascularization, treatment ... #Cardiogenic #HeartFailure ... #Cardiology #Management
Heart Failure (HFrEF) Treatment - GDMT for stage C 

For patients with Heart Failure with REDUCED
Failure (HFrEF) Treatment ... #CHF #sCHF #HeartFailure ... #HFrEF #Pharmacology ... #Management #Treatment ... #StageC #Cardiology
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
with presence of pulmonary ... differential #algorithm #management ... #cardiology #treatment ... table #foamed #heartfailure ... icu #clinical #pharmacology
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
, INC risk PE, Pulmonary ... amyloidosis, PAH ... Adenocarcinoma Treatment ... lubricants • Pharmacologic ... Rheumatology #Diagnosis #Management